Haixia Li - Search Results

Year	Number of Results
2003	4
2004	4
2005	1
2006	2
2007	6
2008	9
2009	12
2010	14
2011	13
2012	22
2013	27
2014	30
2015	32
2016	30
2017	28
2018	45
2019	29
2020	53
2021	59
2022	54
2023	57
2024	9

1

The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry.

Liu X, Si W, He L, Yang J, Peng Y, Ren J, Liu X, Jin T, Yu H, Zhang Z, Cheng X, Zhang W, Xia L, Huang Y, Wang Y, Liu S, Shan L, Zhang Y, Yang X, Li H, Liang J, Sun L, Shang Y. Liu X, et al. Among authors: li h. Signal Transduct Target Ther. 2021 Nov 3;6(1):375. doi: 10.1038/s41392-021-00774-2. Signal Transduct Target Ther. 2021. PMID: 34728602 Free PMC article.

2

Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.

Liang J, Li H, Han J, Jiang J, Wang J, Li Y, Feng Z, Zhao R, Sun Z, Lv B, Tian H. Liang J, et al. Among authors: li h. Cell Death Dis. 2020 Aug 13;11(8):614. doi: 10.1038/s41419-020-02858-3. Cell Death Dis. 2020. PMID: 32792503 Free PMC article.

3

Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.

Li H, Liang J, Wang J, Han J, Li S, Huang K, Liu C. Li H, et al. Cancer Commun (Lond). 2021 Jun;41(6):472-491. doi: 10.1002/cac2.12149. Epub 2021 Feb 27. Cancer Commun (Lond). 2021. PMID: 33638620 Free PMC article.

4

Nitrene transfer reaction with hydroxylamine derivatives.

Gao Y, Li H, Zhao Y, Hu XQ. Gao Y, et al. Among authors: li h. Chem Commun (Camb). 2023 Feb 14;59(14):1889-1906. doi: 10.1039/d2cc06318b. Chem Commun (Camb). 2023. PMID: 36661267 Review.

5

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor.

Sun S, Ding Z, Gao L, Hammock BD, Huang X, Xu ZP, Wang X, Cheng Q, Mo F, Shi W, Xie S, Liu A, Li H, Yang X, Lu X. Sun S, et al. Among authors: li h. Theranostics. 2023 Sep 18;13(14):5099-5113. doi: 10.7150/thno.84946. eCollection 2023. Theranostics. 2023. PMID: 37771772 Free PMC article.

6

Advances in the anti-tumor potential of hederagenin and its analogs.

Xie W, Fang X, Li H, Lu X, Yang D, Han S, Bi Y. Xie W, et al. Among authors: li h. Eur J Pharmacol. 2023 Nov 15;959:176073. doi: 10.1016/j.ejphar.2023.176073. Epub 2023 Sep 22. Eur J Pharmacol. 2023. PMID: 37742813 Review.

7

Nanobody-based CAR T cells targeting intracellular tumor antigens.

Li H, Zhong D, Luo H, Shi W, Xie S, Qiang H, Zhu L, Gao L, Liu J, Sun S, Ding Z, Yang X, Lu X. Li H, et al. Biomed Pharmacother. 2022 Dec;156:113919. doi: 10.1016/j.biopha.2022.113919. Epub 2022 Oct 27. Biomed Pharmacother. 2022. PMID: 36411612 Free article.

8

The roles of microRNA in human cervical cancer.

Miao J, Regenstein JM, Xu D, Zhou D, Li H, Zhang H, Li C, Qiu J, Chen X. Miao J, et al. Among authors: li h. Arch Biochem Biophys. 2020 Sep 15;690:108480. doi: 10.1016/j.abb.2020.108480. Epub 2020 Jul 16. Arch Biochem Biophys. 2020. PMID: 32681832 Review.

9

Super-enhancer-associated gene CAPG promotes AML progression.

Ma Q, Zhao M, Long B, Li H. Ma Q, et al. Among authors: li h. Commun Biol. 2023 Jun 9;6(1):622. doi: 10.1038/s42003-023-04973-1. Commun Biol. 2023. PMID: 37296281 Free PMC article.

10

NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity.

Yang Z, Wilkinson E, Cui YH, Li H, He YY. Yang Z, et al. Among authors: li h. Toxicol Appl Pharmacol. 2023 Oct 15;477:116688. doi: 10.1016/j.taap.2023.116688. Epub 2023 Sep 14. Toxicol Appl Pharmacol. 2023. PMID: 37716414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

469 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Results by year